Financial Statements · Financial Reporting
Bioforce Group OÜ
Official identifier 16260737Record date 31 Dec 2024
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2024
- Period start
- 1 Jan 2024
- Submitted date
- 21 Jul 2025
Report
- Consolidated
- Yes
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Profit distribution proposal | Retained earnings (loss) from previous periods | 4,156,622 |
| Unconsolidated bilanss | Assets | 21,852,746 |
| Unconsolidated bilanss | Cash and cash equivalents | 4,504 |
| Unconsolidated bilanss | Current assets | 3,496,139 |
| Unconsolidated bilanss | Current liabilities | 82,315 |
| Unconsolidated bilanss | Equity | 18,614,081 |
| Unconsolidated bilanss | Share capital at nominal value | 8,140 |
| Unconsolidated bilanss | Non-current assets | 18,356,607 |
| Unconsolidated bilanss | Non-current liabilities | 3,156,350 |
| Unconsolidated bilanss | Retained earnings (loss) from previous periods | 2,365,384 |
| Unconsolidated income statement (scheme 1) | Depreciation and impairment of non-current assets | -17,479 |
| Unconsolidated income statement (scheme 1) | Labour costs | -152,874 |
| Unconsolidated income statement (scheme 1) | Revenue | 443,694 |
| Unconsolidated income statement (scheme 1) | Annual period profit / loss | -1,996 |
| Unconsolidated income statement (scheme 1) | Operating profit (loss) | -245,908 |
| Unconsolidated income statement (scheme 1) | Profit (loss) before income tax | -1,996 |
| Unconsolidated rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | 17,479 |
| Unconsolidated rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | -245,908 |
| Consolidated bilanss | Assets | 44,052,435 |
| Consolidated bilanss | Cash and cash equivalents | 437,443 |
| Consolidated bilanss | Current assets | 4,778,228 |
| Consolidated bilanss | Current liabilities | 11,124,599 |
| Consolidated bilanss | Equity | 5,773,386 |
| Consolidated bilanss | Share capital at nominal value | 8,140 |
| Consolidated bilanss | Non-current assets | 39,274,207 |
| Consolidated bilanss | Non-current liabilities | 27,154,450 |
| Consolidated bilanss | Retained earnings (loss) from previous periods | 4,156,622 |
| Consolidated income statement scheme 1 | Depreciation and impairment of non-current assets | -2,138,094 |
| Consolidated income statement scheme 1 | Labour costs | -1,854,629 |
| Consolidated income statement scheme 1 | Revenue | 20,688,501 |
| Consolidated income statement scheme 1 | Annual period profit / loss | 186,208 |
| Consolidated income statement scheme 1 | Profit (loss) before income tax | 523,083 |
| Consolidated income statement scheme 1 | Operating profit (loss) | 1,855,013 |
| Consolidated rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | 2,138,094 |
| Consolidated rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 1,855,013 |
| Note: Labour costs | Employees | 60 |
| Note: Labour costs | Labour costs | 1,854,629 |
| Employees | 60 |
Linked company
Company: Bioforce Group OÜ